跳至主要内容
临床试验/NCT06259890
NCT06259890招募中不适用

Sodium Intake in spondyLoarthriTes: Analysis of the Influence on the Activity of the Disease and the Therapeutic Response to Anti IL-17A Agents.

Centre Hospitalier Universitaire de Besancon8 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2024年1月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
250
试验地点
8
主要终点
sodium intake

研究概览

简要总结

The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
  • women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)

排除标准

  • patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
  • current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
  • patients on systemic corticosteroids with corticosteroid therapy > 10 mg prednisone equivalent
  • pregnant woman

结局指标

主要结局

sodium intake

时间窗: day of inclusion, monday and tuesday following

average sodium concentration in urine for the week

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Influence of Sodium Intake in spondyLoarthriTes | 临床试验